Annual Shareholders Equity
$535.31 M
+$208.74 M+63.92%
31 December 2023
Summary:
Akero Therapeutics annual stockholders equity is currently $535.31 million, with the most recent change of +$208.74 million (+63.92%) on 31 December 2023. During the last 3 years, it has risen by +$276.59 million (+106.91%). AKRO annual shareholders equity is now at all-time high.AKRO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$738.33 M
-$59.74 M-7.49%
30 September 2024
Summary:
Akero Therapeutics quarterly stockholders equity is currently $738.33 million, with the most recent change of -$59.74 million (-7.49%) on 30 September 2024. Over the past year, it has increased by +$155.19 million (+26.61%). AKRO quarterly shareholders equity is now -12.75% below its all-time high of $846.25 million, reached on 31 March 2024.AKRO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKRO Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +63.9% | +26.6% |
| 3 y3 years | +106.9% | +271.7% |
| 5 y5 years | +1172.3% | +414.9% |
AKRO Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +216.5% | -12.8% | +403.9% |
| 5 y | 5 years | at high | +1172.3% | -12.8% | +612.2% |
| alltime | all time | at high | +1172.3% | -12.8% | +1579.0% |
Akero Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $738.33 M(-7.5%) |
| June 2024 | - | $798.07 M(-5.7%) |
| Mar 2024 | - | $846.25 M(+58.1%) |
| Dec 2023 | $535.31 M(+63.9%) | $535.31 M(-8.2%) |
| Sept 2023 | - | $583.13 M(-5.4%) |
| June 2023 | - | $616.44 M(+101.2%) |
| Mar 2023 | - | $306.35 M(-6.2%) |
| Dec 2022 | $326.56 M(+93.1%) | $326.56 M(-4.9%) |
| Sept 2022 | - | $343.51 M(+131.5%) |
| June 2022 | - | $148.37 M(+1.3%) |
| Mar 2022 | - | $146.53 M(-13.3%) |
| Dec 2021 | $169.11 M | $169.11 M(-14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $198.63 M(-9.8%) |
| June 2021 | - | $220.13 M(-10.5%) |
| Mar 2021 | - | $246.02 M(-4.9%) |
| Dec 2020 | $258.71 M(+101.0%) | $258.71 M(-9.7%) |
| Sept 2020 | - | $286.46 M(+176.3%) |
| June 2020 | - | $103.66 M(-12.4%) |
| Mar 2020 | - | $118.32 M(-8.1%) |
| Dec 2019 | $128.73 M(-357.9%) | $128.73 M(-10.2%) |
| Sept 2019 | - | $143.38 M(-9.5%) |
| June 2019 | - | $158.39 M(+127.4%) |
| Mar 2019 | - | $69.66 M(-239.6%) |
| Dec 2018 | -$49.92 M(+993.8%) | -$49.92 M |
| Dec 2017 | -$4.56 M | - |
FAQ
- What is Akero Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Akero Therapeutics?
- What is Akero Therapeutics annual shareholders equity year-on-year change?
- What is Akero Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Akero Therapeutics?
- What is Akero Therapeutics quarterly shareholders equity year-on-year change?
What is Akero Therapeutics annual stockholders equity?
The current annual shareholders equity of AKRO is $535.31 M
What is the all time high annual shareholders equity for Akero Therapeutics?
Akero Therapeutics all-time high annual stockholders equity is $535.31 M
What is Akero Therapeutics annual shareholders equity year-on-year change?
Over the past year, AKRO annual stockholders equity has changed by +$208.74 M (+63.92%)
What is Akero Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of AKRO is $738.33 M
What is the all time high quarterly shareholders equity for Akero Therapeutics?
Akero Therapeutics all-time high quarterly stockholders equity is $846.25 M
What is Akero Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, AKRO quarterly stockholders equity has changed by +$155.19 M (+26.61%)